SEC Company Response from VOLITIONRX LTD (VNRX) (CIK 0000093314) (VNRX) — Sep 16, 2015
VOLITIONRX LTD (VNRX) (CIK 0000093314)
Date: Sept. 16, 2015 · CIK: 0000093314 · Accession: 0001078782-15-001481
AI Filing Summary & Sentiment
Reasoning
Letter
Acceleration Request
VolitionRx Limited
1 Scotts Road
#24-05 Shaw Centre
Singapore 228208
September 16, 2015
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes
Re:
VolitionRx Limited.
Registration Statement on Form S-3 (File No. 333- 206781)
Acceleration Request
Requested Date:
September 18, 2015
Requested Time:
5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Securities Act.
The Company hereby acknowledges that:
·
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
·
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
·
the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@sycr.com.
Sincerely,
VOLITIONRX LIMITED
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request VolitionRx Limited 1 Scotts Road #24-05 Shaw Centre Singapore 228208 September 16, 2015 SUBMITTED VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Suzanne Hayes Re: VolitionRx Limited. Registration Statement on Form S-3 (File No. 333- 206781) Acceleration Request Requested Date: September 18, 2015 Requested Time: 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Securities Act. The Company hereby acknowledges that: · should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; · the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and · the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@sycr.com. Sincerely, VOLITIONRX LIMITED /s/ Rodney Rootsaert Rodney Rootsaert Secretary cc: VolitionRx Limited Cameron Reynolds, Chief Executive Officer Stradling Yocca Carlson & Rauth, P.C. Marc G. Alcser, Esq. Roy Fox, Esq.